Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 867Carcinoma, Non-Small-Cell Lung 637Prostatic Neoplasms 516Multiple Myeloma 441Neoplasms 425Leukemia, Myeloid, Acute 377Lymphoma 356Leukemia 335Melanoma 333Neoplasm Metastasis 321Lung Neoplasms 308Lymphoma, Non-Hodgkin 302Leukemia, Lymphocytic, Chronic, B-Cell 301Colorectal Neoplasms 281Ovarian Neoplasms 264Pancreatic Neoplasms 249Recurrence 240Precursor Cell Lymphoblastic Leukemia-Lymphoma 239Myelodysplastic Syndromes 233Glioblastoma 212Hodgkin Disease 201Lymphoma, Large B-Cell, Diffuse 197Lymphoma, Follicular 195Brain Neoplasms 194Carcinoma, Renal Cell 189Head and Neck Neoplasms 187Squamous Cell Carcinoma of Head and Neck 186Lymphoma, Mantle-Cell 171Sarcoma 158Fallopian Tube Neoplasms 139

Interventions

Ketoconazole 1Hydrocortisone 1Calcitriol 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Has results × Castration-resistant Prostate Cancer × Clear all
NCT02025010 2025-04-15

Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
60 enrolled 17 charts
Genitourinary

Castration-resistant Prostate Cancer

NCT03261336 2021-02-08

Oral Calcitriol With Ketoconazole in CRPC

Inova Health Care Services

Phase 2 Terminated
1 enrolled 7 charts
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡